Methazolamide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00703 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 30 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary hereditary glaucoma | KG + DL |
| 2 | congestive heart failure | KG + DL |
| 3 | acute pulmonary heart disease | KG + DL |
| 4 | aqueous misdirection | KG + DL |
| 5 | traumatic glaucoma | KG + DL |
| 6 | glaucomatous atrophy of optic disc | KG + DL |
| 7 | neovascular glaucoma | KG + DL |
| 8 | hypotrichosis simplex of the scalp | KG + DL |
| 9 | open angle glaucoma | KG + DL |
| 10 | chronic renal failure syndrome | KG + DL |
| 11 | congenital hypotrichosis milia | KG + DL |
| 12 | chronic kidney disease | KG + DL |
| 13 | glaucoma 1, open angle | KG + DL |
| 14 | end stage renal failure | KG + DL |
| 15 | exercise-induced malignant hyperthermia | KG + DL |
| 16 | familial periodic paralysis | KG + DL |
| 17 | diffuse alopecia areata | KG + DL |
| 18 | chronic pulmonary heart disease | KG + DL |
| 19 | alopecia | KG + DL |
| 20 | myopathic intestinal pseudoobstruction | KG + DL |
| 21 | unclassified intestinal pseudoobstruction | KG + DL |
| 22 | intestinal obstruction | KG + DL |
| 23 | potassium deficiency disease | KG + DL |
| 24 | congenital glaucoma | KG + DL |
| 25 | neuronal intestinal dysplasia, type B | KG + DL |
| 26 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 27 | hypokalemic periodic paralysis | KG + DL |
| 28 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 29 | obsolete bundle branch block | KG + DL |
| 30 | diabetic nephropathy | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.